Cadus Pharmaceutical Corp. (KDUS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS)

KDUS 1.600

0.0%

Jul 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (161)	4/19/2000 12:53:00 PM
From: scaram(o)uche	Read Replies (1) of 1833

Hire? They don't want to hire, IMO. Woler was doing a fine job. They provided incentive for him to leave. Isn't the simplest explanation that platform, cash, potential milestone/royalty flow, and Axiom stake are being shopped? Imagine a "phenotyping" company that's looking to go public. Now try to estimate the difference that it might make to the offering if the company also has capacity for screening and potential royalty flow from OSIP-Solvay or OSIP-proprietary. You take (IMO) $30 million worth of KDUS and turn it into $50 million of new equity. Pretty easy, IMO, to do clever things with the company, and Woler was simply the last impediment.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next